Blend Labs, Inc. (NYSE: BLND) stockholder files notice to sell 25,000 shares

Rhea-AI Filing Summary

An individual named Brian Kneafsey has filed a notice to sell 25,000 shares of Blend Labs, Inc. common stock. The shares are to be sold through Charles Schwab & Co., Inc. on or about 12/15/2025 on the NYSE, with an aggregate market value listed as $76,486.00.

The notice states these shares were acquired on 02/17/2020 in an “Exercise and Hold” transaction from Blend Labs, Inc. for cash. It also discloses prior sales by the same seller over the past three months of 25,000 shares each on 09/15/2025, 10/15/2025, and 11/17/2025, with gross proceeds of $109,069.00, $83,509.00, and $74,732.00, respectively.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	25000	76486.00	256119535	12/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2020	Exercise and Hold	BLEND LABS, INC.			25000	02/17/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	09/15/2025	25000	109069.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	10/15/2025	25000	83509.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	11/17/2025	25000	74732.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Blend Labs (BLND) shares are covered by this sale notice?

The notice covers 25,000 shares of Blend Labs, Inc. common stock to be sold.

When and where are the Blend Labs (BLND) shares expected to be sold?

The approximate sale date is 12/15/2025, with the shares to be sold on the NYSE through Charles Schwab & Co., Inc..

How were the Blend Labs (BLND) shares in this filing originally acquired?

The shares were acquired on 02/17/2020 via an “Exercise and Hold” transaction from Blend Labs, Inc. for cash.

What prior Blend Labs (BLND) share sales by this seller are disclosed?

The filing lists sales of 25,000 shares each on 09/15/2025, 10/15/2025, and 11/17/2025, with gross proceeds of $109,069.00, $83,509.00, and $74,732.00, respectively.

What aggregate market value is listed for the Blend Labs (BLND) shares to be sold?

The aggregate market value listed for the 25,000 shares to be sold is $76,486.00.